Dear readers of ADxS.org, please forgive the disruption.

ADxS.org needs about $53200 in 2024. In 2023 we received donations from third parties of about $ 32200. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2024 would be over after a few days. This donation request is displayed 19,000 times a week, but only 40 people donate. If you find ADxS.org useful, please take a minute and support ADxS.org with your donation. Thank you!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V..

$3391 of $53200 - as of 2024-02-01
6%
Header Image
Levophacetoperan for ADHD

Sitemap

Levophacetoperan for ADHD

Levophacetoperan1

Other names: NLS-3 or (R, R)-enantiomer of phacetoperane
Brand name: Lidepran® (8228 R.P.)

Levophacetoperan is the reverse ester of methylphenidate.
It was marketed in Canada and Europe in the late 1950s to treat ADHD, obesity, and depression.

(Levo-)phacetoperan differs from other stimulants in its effect on the catecholamine system and showed a favorable benefit-risk ratio.
It has been in extensive clinical use in nearly a thousand children and adolescents. It was found to have fewer side effects than comparable stimulant treatments over wide dose ranges.

Diese Seite wurde am 13.03.2023 zuletzt aktualisiert.